Literature DB >> 23408318

Induction, control, and plasticity of Treg cells: the immune regulatory network revised?

Vincenzo Barnaba1, Valeria Schinzari.   

Abstract

Treg cells expressing the Foxp3 transcription factor play a key role in several aspects of immunological tolerance and in the establishment of immune homeostasis. Here, we discuss the mechanisms, including new evidence on the signals required by Tconv cells to convert into Treg cells described by Yao and colleagues [Eur. J. Immunol. 2013. 43: 458-467] in this issue of European Journal of Immunology, by which Treg-cell dynamics, plasticity and diversification correlate with diverse functions (induction, suppression, contra-suppression) in a variety of settings, such as inflammation, chronic infections, cancer, and autoimmunity.
© 2013 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23408318     DOI: 10.1002/eji.201243265

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  11 in total

1.  Hyperprogressive Disease in Patients With Advanced Non-Small Cell Lung Cancer Treated With PD-1/PD-L1 Inhibitors or With Single-Agent Chemotherapy.

Authors:  Roberto Ferrara; Laura Mezquita; Matthieu Texier; Jihene Lahmar; Clarisse Audigier-Valette; Laurent Tessonnier; Julien Mazieres; Gerard Zalcman; Solenn Brosseau; Sylvestre Le Moulec; Laura Leroy; Boris Duchemann; Corentin Lefebvre; Remi Veillon; Virginie Westeel; Serge Koscielny; Stephane Champiat; Charles Ferté; David Planchard; Jordi Remon; Marie-Eve Boucher; Anas Gazzah; Julien Adam; Emilio Bria; Giampaolo Tortora; Jean-Charles Soria; Benjamin Besse; Caroline Caramella
Journal:  JAMA Oncol       Date:  2018-11-01       Impact factor: 31.777

2.  Relevance of Foxp3⁺ regulatory T cells for early and late phases of murine sepsis.

Authors:  Roman Tatura; Michael Zeschnigk; Wiebke Hansen; Joerg Steinmann; Pedrina Goncalves Vidigal; Marina Hutzler; Eva Pastille; Astrid M Westendorf; Jan Buer; Jan Kehrmann
Journal:  Immunology       Date:  2015-07-02       Impact factor: 7.397

3.  Protective effect of cytosolic phospholipase A2 inhibition against inflammation and degeneration by promoting regulatory T cells in rats with experimental autoimmune encephalomyelitis.

Authors:  Dan Yang; Hong-Fei Ji; Xue-Mei Zhang; Hui Yue; Lin Lin; Yu-Yan Ma; Xiang-nan Huang; Jin Fu; Wei-Zhi Wang
Journal:  Mediators Inflamm       Date:  2014-03-23       Impact factor: 4.711

Review 4.  New Insights into Regulatory T Cells: Exosome- and Non-Coding RNA-Mediated Regulation of Homeostasis and Resident Treg Cells.

Authors:  Peiyao Li; Changhong Liu; Zhibin Yu; Minghua Wu
Journal:  Front Immunol       Date:  2016-12-06       Impact factor: 7.561

Review 5.  The Significance of Type-I Interferons in the Pathogenesis and Therapy of Human Immunodeficiency Virus 1 Infection.

Authors:  Bowen Wang; Wen Kang; Jiahui Zuo; Wenzhen Kang; Yongtao Sun
Journal:  Front Immunol       Date:  2017-11-01       Impact factor: 7.561

6.  Hyperprogressive disease during nivolumab or irinotecan treatment in patients with advanced gastric cancer.

Authors:  Masahiko Aoki; Hirokazu Shoji; Kengo Nagashima; Hiroshi Imazeki; Takahiro Miyamoto; Hidekazu Hirano; Yoshitaka Honma; Satoru Iwasa; Natsuko Okita; Atsuo Takashima; Ken Kato; Kazuhide Higuchi; Narikazu Boku
Journal:  ESMO Open       Date:  2019-05-21

Review 7.  Hyperprogressive Disease in Cancers Treated With Immune Checkpoint Inhibitors.

Authors:  Pan Shen; Liang Han; Xin Ba; Kai Qin; Shenghao Tu
Journal:  Front Pharmacol       Date:  2021-07-05       Impact factor: 5.810

8.  Paramyxovirus infection regulates T cell responses by BDCA-1+ and BDCA-3+ myeloid dendritic cells.

Authors:  Meera R Gupta; Deepthi Kolli; Claudio Molteni; Antonella Casola; Roberto P Garofalo
Journal:  PLoS One       Date:  2014-06-11       Impact factor: 3.240

9.  PD-L1 Blockade Differentially Impacts Regulatory T Cells from HIV-Infected Individuals Depending on Plasma Viremia.

Authors:  Cristina Peligero; Jordi Argilaguet; Roberto Güerri-Fernandez; Berta Torres; Carmen Ligero; Pilar Colomer; Montserrat Plana; Hernando Knobel; Felipe García; Andreas Meyerhans
Journal:  PLoS Pathog       Date:  2015-12-03       Impact factor: 6.823

10.  A novel human IL-2 mutein with minimal systemic toxicity exerts greater antitumor efficacy than wild-type IL-2.

Authors:  Xi Chen; Xiaojie Ai; Chunlian Wu; Heyong Wang; Gang Zeng; Peixin Yang; Gentao Liu
Journal:  Cell Death Dis       Date:  2018-09-24       Impact factor: 8.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.